CDK9: Therapeutic perspective in HCC therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Current cancer drug targets"
DOI: 10.2174/1568009620666200212124357
Abstract: CDK9 is an important cell-cycle control enzyme essential in transcription, elongation, and mRNA maturation. Overexpression of CDK9 has been reported in several diseases, including acute lymphoblastic leukemia, chronic lymphocytic leukemia, and malignant melanoma. Recent research… read more here.
Keywords: therapeutic perspective; hcc; cdk9 inhibitors; cdk9 therapeutic ... See more keywords